Abstract
Phosphoinositide (PI) breakdown is an important transmembrane signaling mechanism in rat brain and numerous transmitter receptors are linked to this mechanism. Since agonist-stimulated PI breakdown is often changed after drug pretreatment, assessment of changes in PI breakdown represents an important tool in drug development. PI breakdown is commonly monitored by assaying [ 3H]inositol monophosphate ([ 3H]IP 1) accumulation in the presence of lithium as an inhibitor of inositol monophosphatase. The present protocol presents a lithium-inhibited [ 3H]IP 1 accumulation assay that enhances relatively weak agonist-stimulated [ 3H]IP 1 accumulation signals by thorough oxygenation during agonist stimulation. The protocol is particularly useful in the measurement of [ 3H]IP 1 accumulation after in vitro exposure to relatively weak stimulants, such as serotonin (5-HT), and/or after animal pretreatments that decrease the response to the agonist. In the case of 5-HT stimulation the monoamine oxidase (MAO) inhibitor, tranylcypromine, was added to the incubation medium to inhibit breakdown of exogenous serotonin. We used this protocol to measure 5-HT- and carbachol-stimulated [ 3H]IP 1 accumulation in cortical miniprisms obtained from rats pretreated with d-fenfluramine. d-Fenfluramine is a drug that acutely releases 5-HT into the synaptic cleft [11]and blocks its reuptake [13]. © 1997 Elsevier Science B.V. All rights reserved.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.